Company: ICUI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000883984-25-000035
Chunk: 158

Company: ICU MEDICAL INC/DE
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 8
Chunk 158
---
8.03 %$770,313 Term Loan B — principal7.40 %764,500 8.38 %826,625 Revolving Credit Facility — principal— %— — %— Less unamortized debt issuance costs(1)(10,257)(14,080)Total carrying value of long-term debt1,313,931 1,582,858 Less current portion of long-term debt— 51,000 Long-term debt, net$1,313,931 $1,531,858 _______________________________(1)    Comprised of $3.7 million and $6.5 million relating to the Term Loan A and the Term Loan B, respectively, as of September 30, 2025. Comprised of $6.1 million and $8.0 million relating to the Term Loan A and the Term Loan B, respectively, as of December 31, 2024.

34

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of September 30, 2025, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years and thereafter is approximately (in thousands):Remainder of 2025$— 2026— 2027559,688 2028— 2029764,500 2030— Total$1,324,188 The following table presents the total interest expense related to our long-term debt (in thousands):Three months ended September 30,Nine months ended September 30,2025202420252024Contractual interest$22,815 $32,059 $73,571 $96,186 Amortization of debt issuance costs1,629 1,700 5,112 5,111 Commitment fee — Revolving Credit Facility319 384 1,036 1,141 Total long-term debt-related interest expense$24,763 $34,143 79,719 102,438 We currently hedge against the contractual interest expense on our long-term debt (see Note 9: Derivatives and Hedging Activities).On October 31, 2025, we refinanced the Credit Agreement (see Note 23: Subsequent Event).

Note 19: